These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12985588)

  • 21. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.
    Ishimaru T; Hoshino T; Ichimaru M; Okada H; Tomiyasu T
    Radiat Res; 1971 Jan; 45(1):216-33. PubMed ID: 5275936
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 23. Incidence of Diabetes in the Atomic Bomb Survivors: 1969-2015.
    Tatsukawa Y; Cordova K; Yamada M; Ohishi W; Imaizumi M; Hida A; Sposto R; Sakata R; Fujiwara S; Nakanishi S; Yoneda M
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2148-e2155. PubMed ID: 34918116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia in atomic bomb survivors. I. General observations.
    LANGE RD; MOLONEY WC; YAMAWAKI T
    Blood; 1954 Jun; 9(6):574-85. PubMed ID: 13160106
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences at Nagasaki, Japan.
    HARRIS BR; STEVENS MA
    Conn State Med J; 1945 Dec; 9():913-7. PubMed ID: 21004718
    [No Abstract]   [Full Text] [Related]  

  • 26. Leukemia in atomic bomb survivors. II. Observations on early phases of leukemia.
    MOLONEY WC; LANGE RD
    Blood; 1954 Jul; 9(7):663-85. PubMed ID: 13172286
    [No Abstract]   [Full Text] [Related]  

  • 27. Refractory anemia occurring in survivors of the atomic bombing in Nagasaki, Japan.
    LANGE RD; WRIGHT SW; TOMONAGA M; KURASAKI H; MATSUOKE S; MATSUNAGA H
    Blood; 1955 Apr; 10(4):312-24. PubMed ID: 14363312
    [No Abstract]   [Full Text] [Related]  

  • 28. A long-term cohort study of the atomic-bomb survivors.
    Kodama K; Mabuchi K; Shigematsu I
    J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia.
    Ichimaru M; Ishimaru T; Belsky JL
    J Radiat Res; 1978 Sep; 19(3):262-82. PubMed ID: 739446
    [No Abstract]   [Full Text] [Related]  

  • 30. Autopsy study of leukemia in atomic bomb survivors, Hiroshima-Nagasaki, 1949-1969.
    Liu PI; Ishimaru T; McGregor DH; Yamamoto T; Steer A
    Cancer; 1973 Jun; 31(6):1315-27. PubMed ID: 4513690
    [No Abstract]   [Full Text] [Related]  

  • 31. Hematological investigation of the atomic bomb sufferers in Hiroshima and Nagasaki.
    KIKUCHI T; WAKISAKA G
    Acta Sch Med Univ Kioto; 1952; 30(2):206-37. PubMed ID: 13040081
    [No Abstract]   [Full Text] [Related]  

  • 32. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. D. Leukemia and related disorders.
    Ichimaru M; Ishimaru T
    J Radiat Res; 1975 Sep; 16 Suppl():89-96. PubMed ID: 1104825
    [No Abstract]   [Full Text] [Related]  

  • 33. Thoughts on relief for atomic bomb survivors since Obama's visit to Hiroshima.
    Nagataki S
    Lancet; 2016 Oct; 388(10054):1878-1879. PubMed ID: 27681099
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of polypharmacy on heart rate variability in older adults at the Hiroshima Atomic Bomb Survivors Recuperation Research Center, Japan.
    Okada M; Okada K; Fujii K
    PLoS One; 2018; 13(12):e0209081. PubMed ID: 30540860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observation of spines of persons exposed to the Hiroshima and Nagasaki atomic bomb blasts].
    HASHIMOTO M
    Nagasaki Igakkai Zasshi; 1961 Dec; 36():638-44. PubMed ID: 13905207
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of skin cancer among Nagasaki atomic bomb survivors (preliminary report).
    Sadamori N; Mine M; Hori M; Fujiwara N; Takahara O; Nishimoto K; Ota H; Noda Y; Namba K; Sadamori M
    J Radiat Res; 1990 Sep; 31(3):280-7. PubMed ID: 2246753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray Matter Heterotopia: Histological Evidence of Intrauterine Radiation Exposure in a Nagasaki Atomic Bomb Survivor.
    Akazawa Y; Ito M; Naito S; Kishikawa M; Sekine I; Nakashima M
    Radiat Res; 2019 Dec; 192(6):666-667. PubMed ID: 31560638
    [No Abstract]   [Full Text] [Related]  

  • 40. [Radiation and leukemia: with special reference to those exposed to the Nagasaki atomic bomb blast].
    TOMONAGA M
    Nagasaki Igakkai Zasshi; 1961 Dec; 36():572-81. PubMed ID: 13921809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.